Bent Ejlertsen

1.2k total citations
5 papers, 46 citations indexed

About

Bent Ejlertsen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bent Ejlertsen has authored 5 papers receiving a total of 46 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Bent Ejlertsen's work include BRCA gene mutations in cancer (3 papers), HER2/EGFR in Cancer Research (2 papers) and DNA Repair Mechanisms (2 papers). Bent Ejlertsen is often cited by papers focused on BRCA gene mutations in cancer (3 papers), HER2/EGFR in Cancer Research (2 papers) and DNA Repair Mechanisms (2 papers). Bent Ejlertsen collaborates with scholars based in Denmark, United Kingdom and United States. Bent Ejlertsen's co-authors include Finn C. Nielsen, Mette Klarskov Andersen, Thomas van Overeem Hansen, Lars Jønson, Birgitte Bertelsen, Finn Cilius Nielsen, Claus Storgaard Sørensen, Heike I. Rösner, Grant S. Stewart and Maria Rossing and has published in prestigious journals such as Journal of Clinical Investigation, Breast Cancer Research and Treatment and Acta Oncologica.

In The Last Decade

Bent Ejlertsen

4 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bent Ejlertsen Denmark	2	39	17	12	9	5	5	46
Charlotte Eaton United States	4	31 0.8×	14 0.8×	8 0.7×	8 0.9×	6 1.2×	8	54
Daniel Hüebschmann Germany	3	27 0.7×	12 0.7×	9 0.8×	14 1.6×	8 1.6×	3	49
Mohammad Feroze Fazaludeen Finland	4	22 0.6×	19 1.1×	7 0.6×	9 1.0×	4 0.8×	5	45
Alexis Jiaying Khng Singapore	6	49 1.3×	25 1.5×	20 1.7×	19 2.1×	10 2.0×	13	85
Nadia Nasreddin Switzerland	3	29 0.7×	30 1.8×	13 1.1×	5 0.6×	9 1.8×	4	48
Katharina Ehrenhöfer-Wölfer Austria	2	79 2.0×	21 1.2×	9 0.8×	14 1.6×	14 2.8×	3	92
Catarina Salgado Netherlands	5	36 0.9×	14 0.8×	8 0.7×	8 0.9×	2 0.4×	10	62
Sek Man Su Macao	4	51 1.3×	36 2.1×	13 1.1×	16 1.8×	3 0.6×	5	75
Kevin Ushey Canada	3	69 1.8×	13 0.8×	18 1.5×	10 1.1×	2 0.4×	7	95
Melanie Davila United States	2	30 0.8×	15 0.9×	11 0.9×	10 1.1×	4 0.8×	2	50

Countries citing papers authored by Bent Ejlertsen

Since Specialization

Citations

This map shows the geographic impact of Bent Ejlertsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Ejlertsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Ejlertsen more than expected).

Fields of papers citing papers by Bent Ejlertsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bent Ejlertsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Ejlertsen. The network helps show where Bent Ejlertsen may publish in the future.

Co-authorship network of co-authors of Bent Ejlertsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bent Ejlertsen. A scholar is included among the top collaborators of Bent Ejlertsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bent Ejlertsen. Bent Ejlertsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Frödin, Morten, et al.. (2025). Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects. Journal of Clinical Investigation. 135(12). 1 indexed citations

2.

Jensen, Maj‐Britt, et al.. (2025). Enhancing HER2-low breast cancer detection with quantitative transcriptomics. npj Breast Cancer. 11(1). 98–98.

3.

Nielsen, K., et al.. (2024). Survival outcomes for HER2-low breast cancer: Danish national data. Acta Oncologica. 63. 878–886. 1 indexed citations

4.

Higgs, Martin R., Maria Rossing, Birgitte Bertelsen, et al.. (2020). Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability. Journal of Clinical Investigation. 130(8). 4069–4080. 20 indexed citations

5.

Hansen, Thomas van Overeem, et al.. (2009). The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping. Breast Cancer Research and Treatment. 119(3). 547–550. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact